Inventor

SEMKO CHRISTOPHER

US27 patents

⚠️ This page may combine multiple inventors who share the name “SEMKO CHRISTOPHER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SEMKO CHRISTOPHER

ELAN PHARM INC

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Phenylalanine derivatives as alpha 4 integrin inhibitors

Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Phenylalanine derivatives as alpha 4 integrin inhibitors

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Alpha amino acid derivatives—inhibitors of leukocyte adhesion mediated by VLA-4

Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

REVOLUTION MEDICINES INC

2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors

Ras inhibitors

Ras inhibitors

Pyridine compounds as allosteric SHP2 inhibitors

2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors

2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors

Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors

Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors

WYETH CORP

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

Compounds which inhibit leukocyte adhesion mediated by VLA-4

Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4

Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors